title: Pharmacotherapy for the management of achalasia: Current status, challenges and future directions.
abstract: This article reviews currently available pharmacological options available for the treatment of achalasia, with a special focus on the role of botulinum toxin (BT) injection due to its superior therapeutic effect and side effect profile. The discussion on BT includes the role of different BT serotypes, better pharmacological formulations, improved BT injection techniques, the use of sprouting inhibitors, designer recombinant BT formulations and alternative substances used in endoscopic injections. The large body of ongoing research into achalasia and BT may provide a stronger role for BT injection as a form of minimally invasive, cost effective and efficacious form of therapy for patients with achalasia. The article also explores current issues and future research avenues that may prove beneficial in improving the efficacy of pharmacological treatment approaches in patients with achalasia.
authors.affiliation: Ammar Nassri, Department of Internal Medicine, University of Texas at Austin Dell Medical School, Austin, TX 78701, United States.
authors.forename: Ammar
authors.initials: A
authors.lastname: Nassri
authors.affiliation: Ammar Nassri, Department of Internal Medicine, University of Texas at Austin Dell Medical School, Austin, TX 78701, United States.
authors.forename: Zeeshan
authors.initials: Z
authors.lastname: Ramzan
keywords: Achalasia; Botox; Botulinum toxin; Pharmacotherapy; Sprouting inhibitors